A Study to Evaluate Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve Hepatitis C Virus Genotype 1b-Infected Adults

NCT02582632 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

166

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C Infection
Hepatitis C Virus

Interventions

DRUG: ombitasvir/paritaprevir/ritonavir
DRUG: dasabuvir

Sponsor

AbbVie